Author

J. Osbourn

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cell type annotation· 2 Approach:experimental assay· 2 Organism:human· 2 Assay:bulk RNA-seq· 1 Research Focus:cell-cell communication· 1 Assay:CITE-seq· 1 Research Focus:differential expression· 1

Frequent Co-Authors

J. D. Galson· 2 shared P. Pfeffer· 2 shared W.-Y. J. Lee· 2 shared A. Karatt-Vellatt· 1 shared A. Kovaltsuk· 1 shared A. Leech· 1 shared C. Caldas· 1 shared C. M. Deane· 1 shared

Activity by Year

2020-2020 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 35 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersImmunology

J. D. Galson

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Deep mining of early antibody response in COVID-19 patients yields potent neutralisers and reveals high level of convergence

G. Bullen, J. D. Galson, P. Villar, L. Moreels, L. Ledsgaard, G. Mattiuzzo, G. Hall, E. M. Bentley, E. W. Masters, D. Tang, S. Millett, D. Tongue, R. Brown, I. Diamantopoulos, K. Parthiban, , A. Karatt-Vellatt

The paper identifies potent neutralising antibodies from early COVID-19 patient samples and shows high convergence in antibody sequences across studies.

bioRxiv · Dec 29, 2020 · PreprintImmunology

Deep sequencing of B cell receptor repertoires from COVID-19 patients reveals strong convergent immune signatures

J. D. Galson, S. Schaetzle, R. J. M. Bashford-Rogers, M. I. J. Raybould, A. Kovaltsuk, G. J. Kilpatrick, R. Minter, D. K. Finch, J. Dias, L. James, G. Thomas, W.-Y. J. Lee, J. Betley, O. Cavlan, A. Leech, , J. Osbourn

The paper analyzes B cell receptor repertoires from COVID-19 patients to identify convergent immune signatures associated with disease outcome.

bioRxiv · May 20, 2020Immunology